The report "Cancer Immunotherapy Market by product type (Oncolytic Viral Therapies & Cancer Vaccines, Monoclonal Antibodies, Immunomodulators), by cancer type (Breast, Lung) - Global Forecasts to 2030" The global cancer immunotherapy market is projected to reach USD 120 billion in 2023, registering a Compound Annual Growth Rate (CAGR) of 14.2% during the forecast period 2024-2030. The growth of the market is majorly driven by the increasing adoption of immunotherapy drugs over conventional treatment regimens. Immuno-oncology, another name for cancer immunotherapy, is a type of treatment that uses the body's immune system to locate, target, and destroy cancer cells. Immunotherapy encourages the body's immune system to identify and combat cancer cells, in contrast to conventional cancer therapies like chemotherapy and radiation therapy, which target cancer cells directly. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=27333 Competitive Dashboard: The prominent key players operating in the global Cancer Immunotherapy market are Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Janssen Pharmaceutical, AstraZeneca, Gilead Sciences, Inc., Lilly., Amgen Inc., Novartis AG, GSK plc., Pfizer Inc., Incyte., Celldex Therapeutics, Atara Biotherapeutics, Inc., Cellectis, AbbVie Inc., Bayer AG Regional Overview: The report also examines the current concerns and their Future Effects on the Cancer Immunotherapy Market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the Cancer Immunotherapy Market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
- The cancer immunotherapy market research report includes historical data, trending features, and market growth estimates for the future.
- The qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
- The cancer immunotherapy market report helps to provide the best results for business enhancement and business growth.
- The report gives a comprehensive overview of both primary and secondary data.
- The cancer immunotherapy market key players are covered here to help them strengthen their place in the market.